Osaic Holdings’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Osaic Holdings’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-309	Closed	-$2K	–	7682
2022 Q3	$2K	Hold	309	–	–	﹤0.01%	6909
2022 Q2	$3K	Sell	309 -25	-7%	-$345	﹤0.01%	6812
2022 Q1	$8K	Buy	334 +25	+8%	+$492	﹤0.01%	6300
2021 Q4	$9K	Hold	309	–	–	﹤0.01%	6375
2021 Q3	$20K	Hold	309	–	–	﹤0.01%	5794
2021 Q2	$25K	Hold	309	–	–	﹤0.01%	5528
2021 Q1	$41K	Hold	309	–	–	﹤0.01%	5012
2020 Q4	$49K	Hold	309	–	–	﹤0.01%	4576
2020 Q3	$33K	Hold	309	–	–	﹤0.01%	4606
2020 Q2	$37K	Hold	309	–	–	﹤0.01%	4412
2020 Q1	$24K	Buy	+309	New	+$50.3K	﹤0.01%	4518

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's ELOX Position: Q4 2022 in Review

Osaic Holdings sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 309 shares — an estimated $2K sold.

Osaic Holdings first reported a position in ELOX in Q1 2020 and held it in 11 quarters. The position peaked at $49K in Q4 2020. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

Osaic Holdings reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 309 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $2K.
Osaic Holdings first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
Osaic Holdings's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $49K in Q4 2020.
19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.